News
Projecting $4.0M in net revenue for Q1 2025—up 170% from the prior year—and expects to achieve positive cash flow in the same quarter.

5 December 2024

News
IRVINE, Calif., December 4, 2024 - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its DetermaCNITM assay.

4 December 2024

News
Highly Accomplished Pharmaceutical Leader, Riad El-Dada, Further Enhances Board Expertise

3 December 2024

News
NEW YORK, December 3, 2024 - PRISM MediaWire - AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced the Company entered into Repurchase Agreements with four shareholders, all non-affiliates of th...

3 December 2024

News
Peer-reviewed article highlights potential treatment for OLP with focus on localized drug delivery

3 December 2024

News
· Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population

3 December 2024

News
Next Phase Pilot Study

2 December 2024

News
StemSation International announced today the completion of the acquisition of 100% of the private marketing company, Gorilla Marketing Group, LLC

2 December 2024

News
Skyborne’s Costin Airport Grant Infrastructure Project Has Been Completed for The Near Future Build of New Hangar

2 December 2024

News
Rani Kohen, Founder, and Steve Schmidt, President of SKYX, to Present at 1:30 PM ET on December 3, 2024, and Engage in Investor Meetings Throughout the Conference

27 November 2024

1
2
3
4
5
6
7
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.